Ultragenyx Pharmaceutical, Inc. (RARE)
17.74
+1.04
(+6.20%)
USD |
NASDAQ |
Nov 18, 16:00
17.74
0.00 (0.00%)
After-Hours: 19:42
Ultragenyx Pharmaceutical Total Return Level : 16.70 for Nov. 17, 2026
Total Return Level Chart
Historical Total Return Level Data
| Date | Value |
|---|---|
| November 17, 2026 | 16.70 |
| November 16, 2026 | 15.90 |
| November 13, 2026 | 16.08 |
| November 12, 2026 | 16.27 |
| November 11, 2026 | 16.70 |
| November 10, 2026 | 16.14 |
| November 09, 2026 | 16.41 |
| November 06, 2026 | 15.43 |
| November 05, 2026 | 15.57 |
| November 04, 2026 | 17.16 |
| November 03, 2026 | 16.63 |
| November 02, 2026 | 16.30 |
| October 30, 2026 | 16.10 |
| October 29, 2026 | 16.78 |
| October 28, 2026 | 17.20 |
| October 27, 2026 | 16.75 |
| October 26, 2026 | 16.08 |
| October 23, 2026 | 15.65 |
| October 22, 2026 | 15.95 |
| October 21, 2026 | 15.92 |
| October 20, 2026 | 16.02 |
| October 19, 2026 | 15.07 |
| October 16, 2026 | 14.54 |
| October 15, 2026 | 15.17 |
| October 14, 2026 | 14.90 |
| Date | Value |
|---|---|
| October 13, 2026 | 14.92 |
| October 12, 2026 | 15.30 |
| October 09, 2026 | 15.48 |
| October 08, 2026 | 15.29 |
| October 07, 2026 | 14.89 |
| October 06, 2026 | 14.46 |
| October 05, 2026 | 14.50 |
| October 02, 2026 | 15.22 |
| October 01, 2026 | 14.75 |
| September 30, 2026 | 15.03 |
| September 29, 2026 | 15.32 |
| September 28, 2026 | 14.41 |
| September 25, 2026 | 14.50 |
| September 24, 2026 | 14.77 |
| September 23, 2026 | 14.88 |
| September 22, 2026 | 15.62 |
| September 21, 2026 | 14.65 |
| September 18, 2026 | 14.51 |
| September 17, 2026 | 14.50 |
| September 16, 2026 | 12.88 |
| September 15, 2026 | 13.07 |
| September 14, 2026 | 13.61 |
| September 11, 2026 | 14.30 |
| September 10, 2026 | 14.40 |
| September 09, 2026 | 14.31 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Return Level Benchmarks
| Ionis Pharmaceuticals, Inc. | 26.96 |
| AbbVie, Inc. | 507.46 |
| Krystal Biotech, Inc. | 298.55 |
| BridgeBio Pharma, Inc. | 76.80 |
| Alnylam Pharmaceuticals, Inc. | 156.50 |